Arcutis Biotherapeutics

Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing best-in-class products.

Industries

Biotechnology

Headquarters

Westlake Village, United States

Stage

Post IPO Debt

Employees

51-200

Links

Org chart

Frank Watanabe

President and CEO

Collapse

Patrick Burnett

Chief Medical Officer

David Osborne

Chief Technical Officer

Kenneth Lock

Chief Commercial Officer

Matthew Moore

Chief Business Officer

Raj Madan

Chief Digital & Technology Officer

Courtney Barton

Vice President & Chief Compliance Officer

Don Plummer

Chief of Staff & Head, ESG

Keith Klein

General Counsel

Mas Matsuda

General Counsel

Patricia Turney

Senior Vice President, Operations

Scott Burrows

Vice President, Finance

Bethany Dudek

Vice President, Quality

Ayisha Jeter

Interim Chief Commercial Officer

Kimberly Lathroum

Vice President, Marketing

Charlotte Merritt

Vice President, Regulatory Affairs

Gregory Sukay

Vice President, Manufacturing & Process Technologies

Bruce Binkowitz

Vice President, Biometrics

Jessica Robison

Vice President, Finance & Corporate Controller

Todd Tucker

Vice President, Human Resources

Scott Snyder

Vice President, Product Safety & Pharmacovigilance

David Chu

VP, Clinical Development

Don Plummer

Executive Director, Chief of Staff & Head, ESG

Teams

View all

+19

Leadership Team

22 members

+12

Board of Directors

15 members

CEO and Executive Team

7 members

Founding Team

1 members

Discover similar companies

KindredBio

Burlingame, United States · Post IPO Debt

Halozyme Therapeutics

San Diego, United States · Post IPO Debt

Gritstone Bio

Emeryville, United States · Post IPO Debt

Rani Therapeutics

San Jose, United States · Post IPO Debt

Verastem

Needham, United States · Post IPO Equity

Ardelyx

Fremont, United States · Post IPO Debt

Kymera Therapeutics

Watertown, United States · Post IPO Equity

Kura Oncology

San Diego, United States · Post IPO Debt

Travere Therapeutics

San Diego, United States · Post IPO Equity

Cerevel Therapeutics

Boston, United States · Post IPO Debt

Quince Therapeutics

South San Francisco, United States · Post IPO Equity

Samumed

San Diego, United States · Venture

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.